What the FDA labels say about taking them together
Lurasidone and nelfinavir
Nelfinavir's FDA label of December 11, 2025 names lurasidone in its contraindications section; the lurasidone label PlainMeds reads does not name nelfinavir.
Check it at the source: the lurasidone FDA label on DailyMed (effective January 31, 2025, Sumitomo Pharma America, Inc.); the nelfinavir FDA label on DailyMed (effective December 11, 2025, AGOURON).
What does the lurasidone label say about nelfinavir?
Lurasidone's label (effective January 31, 2025) does not name nelfinavir in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Latuda), NDA200603 (Sunovion Pharms Inc), as published by Sumitomo Pharma America, Inc., effective January 31, 2025 (SPL set afad3051-9df2-4c54-9684-e8262a133af8), via openFDA; the full label on DailyMed
What does the nelfinavir label say about lurasidone?
Nelfinavir label, contraindicationsDrug Class: Antipsychotics; Drugs Within Class That Are Contraindicated With VIRACEPT: Lurasidone Pimozide; Clinical Comment: Potential for serious and/or life-threatening reactions. Potential for serious and/or life threatening reactions such as cardiac arrhythmias.
Source: FDA drug label (VIRACEPT), AGOURON, effective December 11, 2025 (SPL set e72c2bc6-9462-4a2e-8e1d-b97592376cbd), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Lurasidone | Nelfinavir | |
|---|---|---|
| Labeled for | Schizophrenia, Bipolar disorder, Depression | HIV |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $0.142 per tablet 20 mg tablet | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once